Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
120M
-
Number of holders
-
205
-
Total 13F shares, excl. options
-
136M
-
Shares change
-
+2.58M
-
Total reported value, excl. options
-
$3.86B
-
Value change
-
+$69.7M
-
Put/Call ratio
-
0.43
-
Number of buys
-
108
-
Number of sells
-
-111
-
Price
-
$28.40
Significant Holders of Avidity Biosciences, Inc. - Common Stock (RNA) as of Q2 2025
255 filings reported holding RNA - Avidity Biosciences, Inc. - Common Stock as of Q2 2025.
Avidity Biosciences, Inc. - Common Stock (RNA) has 205 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 136M shares
.
Largest 10 shareholders include FMR LLC (16.2M shares), PRICE T ROWE ASSOCIATES INC /MD/ (10.8M shares), JANUS HENDERSON GROUP PLC (10.8M shares), RTW INVESTMENTS, LP (9.62M shares), BlackRock, Inc. (9.34M shares), WELLINGTON MANAGEMENT GROUP LLP (9.25M shares), VANGUARD GROUP INC (9.25M shares), RA CAPITAL MANAGEMENT, L.P. (7.27M shares), Avoro Capital Advisors LLC (7.05M shares), and STATE STREET CORP (4.2M shares).
This table shows the top 205 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.